Albert "Bert" D. Friesen, OM (born May 19, 1947) is a Canadian biotechnologist involved in biotechnology innovation.

[1] His biotechnology career began as the first full-time employee of the Winnipeg Rh Institute, where he later became president and CEO, and led the development of WinRho, one of Canada's first successful biotech products.

[3] In 1987, Dr. Friesen was a founder and the company’s first board of directors Chairman at the Industrial Biotechnology Association of Canada (IBAC) which is now known as BIOTECanada.

In 2020, Medicure purchased Marley Drug and the company can now sell medications directly to patients.

[4] From 2014-2017, Friesen was chair on the International board of MEDA (Mennonite Economic Development Associates).